Read more
20:26 · 15 April 2026

AllBirds: From sneakers to AI, can It work?

Allbirds shares surged more than 500% in today’s session, with the price jumping from roughly $2.5 to around $18, after the footwear maker announced it is raising capital and shifting its business direction to focus on AI computing infrastructure.

The San Francisco, based company has so far focused primarily on manufacturing and selling footwear. It is not large by U.S. standards, just yesterday it was worth only about $25 million, but today its market value is already around $150 million.

The company said it will enter into a $50 million convertible financing agreement with an institutional investor and intends to use the proceeds to purchase graphics processing units (GPUs).

Allbirds also plans to change its name to “NewBird AI” and, over time, shift its focus toward offering cloud computing power and AI services, although it did not provide further details on the new strategy.

Allbirds is a company that could genuinely benefit from a business model overhaul, as despite remaining profitable, both revenue and profits have been declining steadily for several quarters. In recent months, Allbirds has closed most of its brick-and-mortar stores due to weak demand and a shift toward online partnerships. Last month, Allbirds announced that it sold its brand and footwear-related assets to American Exchange Group for $39 million.

This move evokes direct, and rather negative, associations with the dot-com bubble, as well as a number of similar initiatives around 2017 and the speculative bubble in the cryptocurrency market. The market appears to see potential in the company, multiplying its valuation.
It remains a matter of time whether this strategy will prove successful in any meaningful way. Watching whether more entities like Allbirds begin to emerge may provide a lot of information about where the economy currently stands.

15 April 2026, 19:58

"AI" Layoffs: Is it a fiction?

15 April 2026, 18:15

US OPEN: Market hovering near the peaks

10 April 2026, 21:59

Daily summary: Nervous anticipation, SaaS sell-off and weak macro data

10 April 2026, 21:26

“SaaS-pocalypse” continued

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.